A Millennial PhD biochemist on Election Day momentum for cannabis and how you can make a difference by voting for cannabis research.
In this op-ed, Visco calls on the Pennsylvania Governor to create sensible reform, with social equity and bipartisanship in mind.
Direct-to-consumer marketing can prove to be a valuable tool for hemp and CBD companies with less restrictions and a wider reach.
Attorney General William Barr is accused of investigating the MedMen/PharmaCann merger based on his disdain for the cannabis industry. The implications of it could be far-reaching and long lasting.
I truly believe that as brands work to differentiate themselves in the space, leaving a lasting impression will be the catalyst for brands to thrive and grow in an increasingly competitive market while also directly impacting a customer’s lifetime value.
In this op-ed, Silverberg and Chambers argue that tax revenue from legalized cannabis could help a lot of states with their budget problems, while also creating jobs and stimulating the economy.
Our country has had an unfortunate historical relationship with a plant that has the potential to ease suffering safely and bring about some much-needed economic stimulation. It’s high time we fix the mistakes of our past and create a kinder and more inclusive future.
From authentication to tagging and tracing: In this piece, Shearman takes a look at all of the innovative ways growers are elevating cannabis products to luxury status.
A frontline look at the opioid crisis and the emerging alternative of medicinal cannabis.
Failure, the learning experience and the subsequent rapid innovation can often be a blessing in disguise. See how failure helped Dr. Roggen and Soheil Nasseri turn their research into something productive.